检索结果 - Esther Wagena
- Showing 1 - 3 results of 3
-
1
-
2
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb 由 Bettina Weigelin, Elixabet Bolaños, Álvaro Teijeira, Iván Martínez‐Forero, Sara Labiano, Arantza Azpilikueta, Aizea Morales‐Kastresana, José I. Quetglas, Esther Wagena, Alfonso R. Sánchez-Paulete, Lieping Chen, Peter Friedl, Ignacio Melero
出版 2015Artigo -
3
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells 由 Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall, Kim Klarenaar, Paul K.J.D. de Jonge, Janneke S. Hoogstad‐van Evert, Anniek B. van der Waart, Jeannette Cany, Jeffrey T. Safrit, J. H. Lee, Esther Wagena, Peter Friedl, Björn Önfelt, Leon F.A.G. Massuger, Nicolaas Schaap, Joop H. Jansen, Willemijn Hobo, Harry Dolstra
出版 2020Artigo
相关主题
Biology
Cancer research
Cytotoxic T cell
Immune system
Immunology
In vitro
Biochemistry
CTL*
Chemistry
Immunotherapy
Adoptive cell transfer
Agonist
Antibody
Antigen
CD137
CD8
Cancer immunotherapy
Cell biology
Cytokine
Cytotoxicity
DNA
DNA damage
Genetics
In vivo
Interleukin
Interleukin 12
Interleukin 15
Leukemia
Monoclonal antibody
Perforin